title: Authors' reply to Olfson and Schoenbaum, Nardo, Bartlett, Moore, Case, Gøtzsche, and Barber and colleagues.
authors.affiliation: Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA christine_lu@harvardpilgrim.org.
authors.forename: Christine Y
authors.initials: CY
authors.lastname: Lu
authors.affiliation: Group Health Research Institute, Seattle, WA, USA.
authors.forename: Gregory
authors.initials: G
authors.lastname: Simon
authors.affiliation: Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Soumerai
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects*; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D008402:Mass Media; D011358:Product Surveillance, Postmarketing; D013405:Suicide; D014486:United States Food and Drug Administration
chemical_list: D000928:Antidepressive Agents